Protein Information

ID 131
Name C18
Synonyms B1; D1; BBS 9; BBS9; BBS9 GENE; Bardet Biedl syndrome 9 protein; C18; PTH responsive osteosarcoma B1 protein…

Compound Information

ID 1393
Name chloroform
CAS trichloromethane

Reference

PubMed Abstract RScore(About this table)
17702193 Li XL, Li BY, Ni MY, Wang BJ, Guo RC: An improved HPLC method for determination of nifuratel in human plasma and its application to pharmacokinetics studies. Eur J Drug Metab Pharmacokinet. 2007 Apr-Jun;32(2):69-73.
A rapid, simple and sensitive high-performance liquid chromatography (HPLC) method was established for the quantification of nifuratel in human plasma and applied to a study of its pharmacokinetics. A test and a reference formulation were investigated and compared, and the study group consisted of 24 healthy male volunteers. The analytical technique was based on a single extraction of the drug from the plasma with chloroform, using ornidazole as internal standard (IS). The chromatographic system consisted of a 5-microm 4.6 mmX250 mm C18 analytical column and the mobile phase consisted of methanol and purified water (45:55, v/v). Nifuratel and ornidazole concentrations were detected by ultraviolet (UV) absorbance at a wavelength of 254 nm. The lower limit of detection and quantification was 0.5 ng ml (-1), and the calibration curves were linear over a concentration range of 0.5-160 ng ml (-1) nifuratel in the plasma. The results showed that the area under the plasma concentration-time curve (AUC), time to maximum observed plasma concentration (Tmax), maximum concentration reached in the concentration profile (Cmax), and elimination half-life (t1/2) between the test tablets and the reference tablets demonstrated no significant difference (P> 0.05). The relative bioavailability amounted to 103.13% +/-8.73%.
1(0,0,0,1)